The BP would like your views on newly published draft texts
Date Published: 16 October 2024
As part of continued work to ensure the British Pharmacopoeia (BP) is updated with new and improved quality standards and relevant guidance, we routinely upload new and revised draft texts for public consultation and feedback.
It is important to us that you, a user of the BP, have the chance to offer your views on these draft texts before they become a legal standard.
This public consultation period contains 23 draft texts.
12 new monographs for:
• Aripiprazole Oral Solution | • Marbofloxacin for Injection |
• Aripiprazole Orodispersible Tablets | • Marbofloxacin Injection |
• Aripiprazole Tablets | • Marbofloxacin Tablets |
• Cyperus Rotundus Rhizome | • Tramadol Dispersible Tablets |
• Diltiazem Cream | • Tramadol Orodispersible Tablets |
• Lansoprazole Oral Suspension | • Tramadol Soluble Tablets |
11 revised monographs for:
• Epirubicin Injection | • Nifedipine Prolonged-release Capsules |
• Flucloxacillin Oral Solution | • Nifedipine Prolonged-release Tablets |
• Metronidazole Infusion | • Squill |
• Metronidazole Suppositories | • Trimethoprim Oral Suspension |
• Metronidazole Tablets | • Trimethoprim Tablets |
• Nifedipine Capsules |
Submitting your views
All draft texts are listed on our site with specific instructions about how to submit your comments. The deadline for this round is 31 December 2024.
Thank you for your valuable contribution to this process.
The 2025 edition of the British Pharmacopoeia is now available to order. Ensure you’re fully compliant with new standards.